These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1687022)
1. The disposition and metabolism of [14C]piritrexim in dogs after intravenous and oral administration. Woolley JL; Deangelis DV; Grace ME; Liao SH; Crouch RC; Sigel CW Drug Metab Dispos; 1991; 19(6):1139-46. PubMed ID: 1687022 [TBL] [Abstract][Full Text] [Related]
2. The disposition and metabolism of [14C]piritrexim in rats after intravenous and oral administration. Woolley JL; Deangelis DV; Crouch RC; Shockcor JP; Sigel CW Drug Metab Dispos; 1991; 19(3):600-8. PubMed ID: 1680625 [TBL] [Abstract][Full Text] [Related]
3. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog. Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500 [TBL] [Abstract][Full Text] [Related]
4. Disposition and metabolism of finasteride in dogs. Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636 [TBL] [Abstract][Full Text] [Related]
5. Preclinical biochemical pharmacology and toxicology of piritrexim, a lipophilic inhibitor of dihydrofolate reductase. Sigel CW; Macklin AW; Woolley JL; Johnson NW; Collier MA; Blum MR; Clendeninn NJ; Everitt BJ; Grebe G; Mackars A NCI Monogr; 1987; (5):111-20. PubMed ID: 3431588 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in the dog. Shukla UA; Marathe PH; Pittman KA; Barbhaiya RH Drug Metab Dispos; 1993; 21(3):502-7. PubMed ID: 8100508 [TBL] [Abstract][Full Text] [Related]
7. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs. Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in humans. Barbhaiya RH; Dandekar KA; Greene DS Drug Metab Dispos; 1996 Jan; 24(1):91-5. PubMed ID: 8825195 [TBL] [Abstract][Full Text] [Related]
10. Disposition of acrivastine in the male beagle dog. McNulty MJ; Deal DL; Nelson FR; Weller S; Chandrasurin P; Shockcor J; Findlay JW Drug Metab Dispos; 1992; 20(5):679-87. PubMed ID: 1358572 [TBL] [Abstract][Full Text] [Related]
12. Disposition of [14C]velnacrine maleate in rats, dogs, and humans. Turcan RG; Hillbeck D; Hartley TE; Gilbert PJ; Coe RA; Troke JA; Vose CW Drug Metab Dispos; 1993; 21(6):1037-47. PubMed ID: 7905382 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and disposition in the rat of a DNA intercalator 502U83. Patel DK; Lewis RP; Hinton ML; Schroeder DH; Shockcor JP; Johnson RL; Sigel CW Drug Metab Dispos; 1993; 21(1):62-70. PubMed ID: 8095228 [TBL] [Abstract][Full Text] [Related]
14. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans. Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130 [TBL] [Abstract][Full Text] [Related]
15. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse. Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957 [TBL] [Abstract][Full Text] [Related]
16. Bioavailability, metabolism, and renal excretion of benzoic acid in the channel catfish (Ictalurus punctatus). Plakas SM; James MO Drug Metab Dispos; 1990; 18(5):552-6. PubMed ID: 1981701 [TBL] [Abstract][Full Text] [Related]
17. Metabolism and disposition of [14C]BMS-690514 after oral administration to rats, rabbits, and dogs. Hong H; Su H; Sun H; Allentoff A; Ekhato IV; Chando T; Caceres-Cortes J; Roongta V; Iyer RA; Humphreys WG; Christopher LJ Drug Metab Dispos; 2010 Jul; 38(7):1189-201. PubMed ID: 20363952 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey. Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962 [TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of 1,3-di(4-imidazolino-2-methoxyphenoxy) propane.lactate (DMP.lactate), a new agent against opportunistic infections, in male beagle dogs. Bekersky I; Puhl RJ; Hanson G; Mong S Drug Metab Dispos; 1994; 22(2):233-6. PubMed ID: 8013279 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic study of [14C]flutrimazole after oral and intravenous administration in dogs. Comparison with clotrimazole. Conte L; Ramis J; Mis R; Vilageliu J; Basi N; Forn J Arzneimittelforschung; 1992 Jun; 42(6):854-8. PubMed ID: 1418045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]